Mita MM - Search Results

1

Gong J, Sachdev E, Robbins LA, Lin E, Hendifar AE, Mita MM. Gong J, et al. Among authors: mita mm. Oncol Lett. 2017 Mar;13(3):1035-1040. doi: 10.3892/ol.2017.5572. Epub 2017 Jan 4. Oncol Lett. 2017. PMID: 28454210 Free PMC article.

2

Ridaforolimus in advanced or metastatic soft tissue and bone sarcomas.

Mita MM, Gong J, Chawla SP. Mita MM, et al. Expert Rev Clin Pharmacol. 2013 Sep;6(5):465-82. doi: 10.1586/17512433.2013.827397. Epub 2013 Aug 23. Expert Rev Clin Pharmacol. 2013. PMID: 23971829 Review.

3

Activated ras signaling pathways and reovirus oncolysis: an update on the mechanism of preferential reovirus replication in cancer cells.

Gong J, Mita MM. Gong J, et al. Among authors: mita mm. Front Oncol. 2014 Jun 26;4:167. doi: 10.3389/fonc.2014.00167. eCollection 2014. Front Oncol. 2014. PMID: 25019061 Free PMC article. Review.

4

Adnectin-targeted inhibitors: rationale and results.

Sachdev E, Gong J, Rimel B, Mita M. Sachdev E, et al. Curr Oncol Rep. 2015 Aug;17(8):35. doi: 10.1007/s11912-015-0459-8. Curr Oncol Rep. 2015. PMID: 26045129

5

The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.

Gong J, Kelekar G, Shen J, Shen J, Kaur S, Mita M. Gong J, et al. Target Oncol. 2016 Aug;11(4):447-67. doi: 10.1007/s11523-016-0423-z. Target Oncol. 2016. PMID: 26864078 Review.

6

Clinical development of reovirus for cancer therapy: An oncolytic virus with immune-mediated antitumor activity.

Gong J, Sachdev E, Mita AC, Mita MM. Gong J, et al. Among authors: mita mm, mita ac. World J Methodol. 2016 Mar 26;6(1):25-42. doi: 10.5662/wjm.v6.i1.25. eCollection 2016 Mar 26. World J Methodol. 2016. PMID: 27019795 Free PMC article. Review.

7

Aldoxorubicin for the treatment of soft tissue sarcoma.

Sachdev E, Sachdev D, Mita M. Sachdev E, et al. Expert Opin Investig Drugs. 2017 Oct;26(10):1175-1179. doi: 10.1080/13543784.2017.1371134. Epub 2017 Aug 28. Expert Opin Investig Drugs. 2017. PMID: 28846045 Review.

8

PARP Inhibition in Cancer: An Update on Clinical Development.

Sachdev E, Tabatabai R, Roy V, Rimel BJ, Mita MM. Sachdev E, et al. Among authors: mita mm. Target Oncol. 2019 Dec;14(6):657-679. doi: 10.1007/s11523-019-00680-2. Target Oncol. 2019. PMID: 31625002 Review.

9

Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer.

Sarantopoulos J, Mita MM, Birrer MJ, Cranmer LD, Campos LT, Zhang X, Bristow P, Kaito H, Strout V, Camacho LH. Sarantopoulos J, et al. Among authors: mita mm. Target Oncol. 2016 Jun;11(3):317-27. doi: 10.1007/s11523-015-0394-5. Target Oncol. 2016. PMID: 26507836 Clinical Trial.

10

Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics.

Tabatabai R, Linhares Y, Bolos D, Mita M, Mita A. Tabatabai R, et al. Target Oncol. 2017 Oct;12(5):623-641. doi: 10.1007/s11523-017-0507-4. Target Oncol. 2017. PMID: 28653295 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters